Back to News
Market Impact: 0.35
Axogen, Inc. Reports Third Quarter 2026 Financial Results and Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Axogen reported Q3 2026 revenue of $75.8 million, up 26.2% from $60.1 million in Q3 2025. Net income increased to $2.3 million, or $0.04 per share, from $0.7 million a year earlier; the provided article text contains no expectations or guidance details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
AXGN0.65
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Asian shares fall as Alphabet earnings miss drags Wall St futures lower